Changes are coming in 2026 for GLP-1 drugs. Long defined by high prices, shortages and weekly injections, drugs including ...

Novo Nordisk’s new Wegovy pill hit the market this week. The Danish drug maker, best known for GLP-1 injections like Ozempic ...

The global auto-injectors market is rapidly evolving, emerging as one of the most dynamic segments of medical devices and pharmaceutical delivery systems. According to a FutureWise Research analysis, ...

Americans seeking to lose weight now have a new option – taking Wegovy as a daily pill, rather than a weekly injection.

The treatment also prevented the development of arthritis after knee injuries such as ACL tears often experienced by athletes ...

Dec 23 () - The weight-loss drug market is surging, with biotech firms racing to win share in a sector dominated by Novo Nordisk and Eli Lilly. Analysts forecast the industry will generate about $150 ...

Until recently, the popular weight loss treatment called Wegovy was only available in injection form. The newly-launched ...

Danish drug major Novo Nordisk has received US Food and Drug Administration (FDA) approval to sell its blockbuster weight loss drug Wegovy (semaglutide 25 mg) as once a day oral pill in that country.

Takeda and Protagonist Therapeutics have submitted a new drug application to the FDA for rusfertide for adults with ...

A treatment that blocks an age-related protein restored cartilage in aging and injured joints by reprogramming existing cells ...

The FDA has approved the first-ever Wegovy pill for weight loss, with the oral GLP-1 offering a 16.6% average weight reduction as a needle-free alternative.